Back to results
US 7,732,473 B2Granted
Compounds with nootropic action, their preparation, pharmaceutical compositions containing them, and use thereof
AssigneeNeurotune AG
InventorsCarlo Farina, Stefania Gagliardi, Carlo Parini, Marisa Martinelli, Carla Ghelardini
Life of this patent
Estimating the term…
Abstract
Described herein are new bicyclic arylimidazolones having nootropic action (i.e., protecting and stimulating cerebral functions), analgesic action and anti hyperalgesic action; also described is the process for their preparation and pharmaceutical compositions comprising them, useful for the treatment of cognitive deficits, and of various types of pain.
Claims8
A process for the preparation of compounds of the general formula (I)
- wherein:
- A is selected from the group consisting of carbocyclic aromatic groups, heterocyclic aromatic groups, and arylC1-4alkyl;
- R1 is selected from the group consisting of:
- hydrogen,
- arylC1-7alkyl, optionally substituted on the aryl moiety with one or more groups chosen among hydroxy, C1-4alkoxy, halogen, haloC1-4alkyl;
- heterocyclylC1-7alkyl, optionally substituted on the heterocyclyl moiety with one or more groups chosen among C1-4alkyl and hydroxy;
- and
- C1-7 alkyl, optionally interrupted by an oxygen or sulphur atom or optionally substituted at any position by one or more groups chosen among hydroxy, thio, amino, carboxyl, aminocarbonyl, guanidinyl;
- R2 is selected from the group consisting of hydrogen, C1-4alkyl, arylC1-4alkyl and phenyl;
- or else R1 and R2, taken together, form a saturated carbocyclic ring containing from 3 to 8 carbon atoms;
- R3 is selected from the group consisting of hydrogen, C1-4alkyl, arylC1-4alkyl, CONH2 and COOR5 in which R5 is selected from the group consisting of hydrogen and C1-4alkyl;
- R4 is selected from the group consisting of hydrogen, C1-4alkyl, aryl, arylC1-4alkyl and heterocyclyl;
- n is 2, 3 or 4;
- in the form of a racemic mixture or in the form of enantiomers, and pharmaceutically acceptable salts thereof, comprising the following stages:
- i) reacting an aminoacid of formula (IV) or of one of its activated derivatives
- with a compound of formula (V)
- A-NH2 (V)
- to obtain a compound of formula (VI):
- in which R1, R2 and A are as defined above, and P is H or a suitable protective group;
- ii) reacting the compound of formula (VI) obtained in stage i) with a compound of formula (VII)
- to obtain a compound of formula (VIII)
- in which A, R1, R2, R3, R4 and n are as defined above, P is defined as above, and R′ is an alkyl group;
- iii) optionally removing the protective group P by means of hydrogenolysis of the compound of formula (VIII) obtained from stage ii), to obtain the corresponding compound (VIII), in which P is H;
- and
- iv) cyclizing of the compound of formula (VIII), in which P is H coming from stage ii) or from stage iii), to obtain the desired compound of formula (I).
22 more elements
Dependencies are inferred from the claim text.